PE Tech Report


Like this article?

Sign up to our free newsletter

Blue Wolf Capital invests in North American Rescue

Blue Wolf Capital Partners has acquired a majority stake in North American Rescue (NAR), a supplier of tactical medical products, such as tourniquets, chest seals and decompression needles.

North American Rescue’s clients include the military, law enforcement and EMS first responders.

NAR’s Chief Executive Officer, Bob Castellani, and other members of the NAR management team invested alongside Blue Wolf and will remain in their current positions. Michael Ranson, Vic Caruso and Aakash Patel of Blue Wolf will join the Company’s Board of Directors. Renaissance Strategic Advisors and Holland & Knight provided advisory services to Blue Wolf on this transaction. Additional terms of the transaction were not disclosed.

Ranson, Partner at Blue Wolf, says: “We are excited to invest alongside Bob and management in NAR. Operating in a market that serves our country’s national interests, the Company has established itself as a leading player with a strong competitive position. NAR’s products are of the highest quality and are mission-critical in saving lives. We are eager to execute on the Company’s organic growth and acquisition opportunities.”

Castellani says: “Blue Wolf’s relationships within the defence and medical industry will create additional growth opportunities for NAR. Their track record of using strategic acquisitions to grow their portfolio companies will prove valuable as we seek to expand the Company’s product offering and better serve the unique requirements of our customers. We are excited that Blue Wolf shares our passion for customers and their missions and recognises the sacrifices these customers make for our country every day.”

Adam Blumenthal, Managing Partner at Blue Wolf, adds: “The NAR transaction touches on several areas of Blue Wolf’s investment focus. We have a long history of successfully partnering with existing management teams. In addition, we have a strong track record of investing in middle market defense and healthcare businesses, and we plan to deploy meaningful capital in those sectors in the future. We look forward to working with Bob and his team to build on the Company’s success.”

Like this article? Sign up to our free newsletter